Ignite Creation Date:
2024-05-06 @ 1:17 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03979131
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-26
First Post:
2019-06-06
Brief Title:
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer GC or Gastroesophageal Junction Cancer GEJC
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Organization Data
Organization:
Vall dHebron Institute of Oncology
Class:
OTHER
Study ID:
VHIO19001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vall dHebron Institute of Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None